| RS1555165494 |
COL2A1
|
Health Risk |
Pathogenic |
COL2A1-related disorder, Achondrogenesis type II |
| RS1555165501 |
COL2A1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555165503 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1555165565 |
MEN1
|
Health Risk |
Pathogenic |
Ependymoma, Ependymoma |
| RS1555165570 |
MEN1
|
Health Risk |
Likely pathogenic |
— |
| RS1555165597 |
MEN1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1555165756 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1555165809 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1555165811 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS1555166013 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1555166218 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS1555166294 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS1555166295 |
COL2A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS1555166365 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1555166368 |
MEN1
|
Health Risk |
Pathogenic |
6 conditions, Multiple endocrine neoplasia |
| RS1555166387 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1555166435 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1555166457 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1555166466 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1555166469 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS1555166494 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1555166528 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
— |
| RS1555166537 |
COL2A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS1555166555 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS1555166557 |
MEN1
|
Health Risk |
Conflicting classifications of pathogenicity |
Multiple endocrine neoplasia, type 1 |
| RS1555166567 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1555166609 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1555166658 |
COL2A1
|
Health Risk |
Pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS1555166664 |
MEN1
|
Health Risk |
Likely pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1555166681 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1555166695 |
MEN1
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary cancer-predisposing syndrome, Multiple endocrine neoplasia |
| RS1555166711 |
MEN1
|
Health Risk |
Pathogenic |
Multiple endocrine neoplasia, type 1 |
| RS1555166729 |
COL2A1
|
Health Risk |
Likely pathogenic |
Achondrogenesis type II, Achondrogenesis type II |
| RS1555166808 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1555166826 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS1555166943 |
MARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
Charcot-Marie-Tooth disease axonal type 2U, Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency |
| RS1555167058 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS1555167067 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1555167139 |
COL2A1
|
Health Risk |
Likely pathogenic |
Connective tissue disorder, Connective tissue disorder |
| RS1555167140 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1555167156 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1555167157 |
COL2A1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555167299 |
KIF21A
|
Health Risk |
Likely pathogenic |
KIF21A-related disorder, KIF21A-related disorder |
| RS1555167368 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1555167372 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS1555167439 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1555167449 |
COL2A1
|
Health Risk |
Pathogenic |
— |
| RS1555167566 |
IRAK4
|
Health Risk |
Pathogenic |
Immunodeficiency 67, Immunodeficiency 67 |
| RS1555167770 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS1555167783 |
COL2A1
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia congenita, Spondyloepiphyseal dysplasia congenita |
| RS1555167847 |
COL2A1
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555168270 |
MARS1
|
Health Risk |
Conflicting classifications of pathogenicity |
MARS-related disorder, Severe early-onset pulmonary alveolar proteinosis due to MARS deficiency |
| RS1555168309 |
COL2A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS1555168505 |
COL2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Spondyloepimetaphyseal dysplasia, Strudwick type |
| RS1555168542 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS1555168840 |
COL2A1
|
Health Risk |
Likely pathogenic |
— |
| RS1555168965 |
COL2A1
|
Health Risk |
Likely pathogenic |
Stickler syndrome type 1, Stickler syndrome type 1 |
| RS1555169270 |
IRAK4
|
Health Risk |
Likely pathogenic |
Immunodeficiency 67, Immunodeficiency 67 |
| RS1555170507 |
CHD4
|
Health Risk |
Likely pathogenic |
CHD4-related disorder, CHD4-related disorder |
| RS1555171158 |
KRT1
|
Health Risk |
Pathogenic |
Congenital reticular ichthyosiform erythroderma, Congenital reticular ichthyosiform erythroderma |
| RS1555171247 |
KRT1
|
Health Risk |
Pathogenic/Likely pathogenic |
6 conditions, 6 conditions |
| RS1555171293 |
CHD4
|
Health Risk |
Likely pathogenic |
— |
| RS1555171527 |
KRT1
|
Health Risk |
Likely pathogenic |
— |
| RS1555174708 |
DRC2
|
Health Risk |
Pathogenic |
Primary ciliary dyskinesia 27, Primary ciliary dyskinesia 27 |
| RS1555176945 |
PEX5
|
Health Risk |
Pathogenic/Likely pathogenic |
PEX5-related disorder, Peroxisome biogenesis disorder 2B |
| RS1555177629 |
KIF5A
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia, Spastic paraplegia |
| RS1555177824 |
KIF5A
|
Health Risk |
Pathogenic/Likely pathogenic |
Hereditary spastic paraplegia, Hereditary spastic paraplegia 10 |
| RS1555177831 |
KIF5A
|
Health Risk |
Likely pathogenic |
Hereditary spastic paraplegia, Hereditary spastic paraplegia |
| RS1555177994 |
WNT10B
|
Health Risk |
Pathogenic |
Split hand-foot malformation 6, Split hand-foot malformation 6 |
| RS1555178348 |
KIF5A
|
Health Risk |
Conflicting classifications of pathogenicity |
Spastic paraplegia, Spastic paraplegia |
| RS1555178358 |
NUP107
|
Health Risk |
Pathogenic |
Ovarian dysgenesis 6, Ovarian dysgenesis 6 |
| RS1555178616 |
KIF5A
|
Health Risk |
Pathogenic/Likely pathogenic |
Spastic paraplegia, Spastic paraplegia |
| RS1555178899 |
WNT1
|
Health Risk |
Likely pathogenic |
Osteogenesis imperfecta type 15, Osteogenesis imperfecta type 15 |
| RS1555179087 |
KIF5A
|
Health Risk |
Pathogenic/Likely pathogenic |
Amyotrophic lateral sclerosis, susceptibility to |
| RS1555179091 |
KIF5A
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis, susceptibility to |
| RS1555179320 |
ABCC9
|
Health Risk |
Pathogenic/Likely pathogenic |
Dilated cardiomyopathy 1O, Inborn genetic diseases |
| RS1555179699 |
MIP
|
Health Risk |
Pathogenic |
— |
| RS1555179713 |
MIP
|
Health Risk |
Pathogenic |
Cataract 15 multiple types, Cataract 15 multiple types |
| RS1555184609 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 1, KMT2D-related disorder |
| RS1555184624 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Seizure |
| RS1555184635 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1555184684 |
KMT2D
|
Health Risk |
Likely pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555184777 |
KMT2D
|
Health Risk |
Pathogenic/Likely pathogenic |
Kabuki syndrome, Kabuki syndrome 1 |
| RS1555184782 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome |
| RS1555184787 |
KMT2D
|
Health Risk |
Pathogenic |
Inborn genetic diseases, Inborn genetic diseases |
| RS1555184893 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1555185217 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome, Kabuki syndrome 1 |
| RS1555185299 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome, Kabuki syndrome |
| RS1555185301 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1555185337 |
KMT2D
|
Health Risk |
Likely pathogenic |
— |
| RS1555185358 |
KMT2D
|
Health Risk |
Likely pathogenic |
— |
| RS1555185610 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1555185699 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1555185701 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 1, Kabuki syndrome |
| RS1555185778 |
CNTN1
|
Health Risk |
Likely pathogenic |
Compton-North congenital myopathy, Compton-North congenital myopathy |
| RS1555185817 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1555185875 |
KMT2D
|
Health Risk |
Conflicting classifications of pathogenicity |
Kabuki syndrome 1, Kabuki syndrome |
| RS1555185969 |
KMT2D
|
Health Risk |
Pathogenic |
Kabuki syndrome 1, Kabuki syndrome |
| RS1555185978 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |
| RS1555186044 |
KMT2D
|
Health Risk |
Likely pathogenic |
Kabuki syndrome 1, Kabuki syndrome 1 |